The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
870
May 15, 1992
View Complete Issue         Table of Contents 2019 
Clarithromycin and Azithromycin
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Clarithromycin and Azithromycin
May 15, 1992 (Issue: 870)
Clarithromycin (Biaxin - Abbott) and azithromycin (Zithromax - Pfizer), two macrolide antibiotics chemically related to erythromycin, have been approved by the US Food and Drug Administration for treatment of respiratory, skin, and skin structure...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Clarithromycin and Azithromycin
Article code: 870a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.